Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves

Giuseppe Tarantini*, Janarthanan Sathananthan, Tommaso Fabris, Uri Landes, Vinayak N Bapat, Jaffar M Khan, Luca Nai Fovino, Syed Zaid, Nicolas M Van Mieghem, Azeem Latib, Ron Waksman, Ole De Backer, Toby Rogers, Lars Søndergaard, Gilbert H L Tang*

*Corresponding author af dette arbejde


Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients. Given the longer life expectancy of these patients, the bioprosthetic valve will eventually fail, and aortic valve reintervention may be necessary. Although currently rare, redo-TAVR will likely increase in the future as younger patients are expected to outlive their transcatheter bioprosthesis. This review provides a contemporary overview of the indications, procedural planning, implantation technique, and outcomes of TAVR in failed transcatheter bioprosthetic aortic valves.

TidsskriftJACC. Cardiovascular interventions
Udgave nummer18
Sider (fra-til)1777-1793
Antal sider17
StatusUdgivet - 26 sep. 2022


Dyk ned i forskningsemnerne om 'Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves'. Sammen danner de et unikt fingeraftryk.